Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

NCT04521231

Conditions
B Cell Precursor Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of California San Francisco Fresno at Community Cancer Institute Clovis, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

NCT02392429

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Mount Sinai Hospital New York, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Active, Not Recruiting

Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

NCT02477696

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Anaheim, California, United States
  • Research Site Berkeley, California, United States
  • Research Site Duarte, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

NCT02632708

Conditions
AML Arising After Exposure to Genotoxic Injury, AML Arising From Antecedent Hematologic Disorder (AHD), AML Arising From Myelodysplastic Syndrome (MDS), +9 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT05057494

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Longmont, Colorado, United States
  • Research Site Jacksonville, Florida, United States
View all 37 locations
View Trial Details

Related conditions